Guides to stocks, ETFs and stock indices for crypto users: how tokenized stocks and stock perpetual futures work, what you actually hold, the costs and risks, and how to trade them on Bitbase.
Guides to stocks, ETFs and stock indices for crypto users: how tokenized stocks and stock perpetual futures work, what you actually hold, the costs and risks, and how to trade them on Bitbase.

2026-11-07

2026-11-07

2026-11-07

2026-11-07

2026-11-07

2026-11-07

2026-11-07

2026-11-07

2026-11-07

2026-11-07

Buy Bristol Myers Squibb (BMY) through any broker with NYSE access. Eliquis and Opdivo brought in about 51% of 2025 revenue; see order steps and patent dates.
2026-11-07

Buy Marathon Petroleum (MPC) via any broker with NYSE access. Refining made 93.6% of 2025 revenue; see MPLX's role, the Marathon Oil split and the dividend.
2026-11-07

Buy Capital One (COF) through a broker with NYSE access. Cards made 74% of its 2025 revenue; see the order steps, the Discover deal, the dividend and risks.
2026-11-07

Buy Altria (MO) through any broker with NYSE access. Smokeable products were 88.0% of 2025 net revenues; see the order steps, PMI spin-off and dividend.
2026-11-07

Buy BP as a NYSE ADS worth six ordinary shares, or in London. Oil production earned nearly half of 2025 segment profit; steps, stamp duty, dividend, risks.
2026-11-07

Buy British American Tobacco (BTI) as an NYSE-listed ADS backed by one London share. The US brought 45.0% of 2025 revenue; steps, dividend, UK tax, risks.
2026-11-07

Buy Progressive (PGR) through a broker with NYSE access. Its 2025 combined ratio was 87.4% against a 96% goal; see the steps, variable dividend and risks.
2026-11-07

Buy BBVA on the NYSE as an ADS equal to one Spanish share, or in euros in Madrid. Mexico made about 45% of 2025 segment profit; steps, Spanish tax, risks.
2026-11-07

Buy Rio Tinto as RIO, a NYSE ADS backed by one plc share, or in London or Sydney. Copper, aluminium and lithium earned over half of H1 2026 EBITDA.
2026-11-07

Buy Vertex Pharmaceuticals (VRTX) through a broker with Nasdaq access. CF drugs made up about 98% of 2025 revenue; see the order steps, patents and risks.
2026-11-07